President Trump outlined a healthcare affordability framework he wants Congress to consider, centered on sending federal funds directly to American consumers through health savings accounts (HSAs) to purchase insurance and cover medical costs following the expiration of enhanced Affordable Care Act (ACA) premium subsidies at the end of 2025. The plan also calls for lowering drug prices by tying U.S. prices to those paid in other countries, expanding direct-to-consumer drug sales through TrumpRx, and allowing certain medications to be sold over the counter if deemed safe, while requiring insurers to disclose more information on pricing, denied claims, and wait times. The framework was released as bipartisan Senate talks to revive the enhanced ACA subsidies remain stalled, with negotiators acknowledging legislative text will not be ready until late January due to continued disputes over abortion-related funding restrictions.
